- Home
- GLMD vs SNTG Comparison
GLMD vs SNTG Comparison
Compare GLMD & SNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- SNTG
- Stock Information
- Founded
- GLMD 2000
- SNTG 2009
- Country
- GLMD Israel
- SNTG China
- Employees
- GLMD N/A
- SNTG N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- SNTG Finance: Consumer Services
- Sector
- GLMD Health Care
- SNTG Finance
- Exchange
- GLMD Nasdaq
- SNTG Nasdaq
- Market Cap
- GLMD 4.5M
- SNTG 5.2M
- IPO Year
- GLMD 2014
- SNTG 2021
- Fundamental
- Price
- GLMD $1.30
- SNTG $1.45
- Analyst Decision
- GLMD Hold
- SNTG
- Analyst Count
- GLMD 1
- SNTG 0
- Target Price
- GLMD N/A
- SNTG N/A
- AVG Volume (30 Days)
- GLMD 2.6M
- SNTG 14.6K
- Earning Date
- GLMD 05-29-2025
- SNTG 04-25-2025
- Dividend Yield
- GLMD N/A
- SNTG N/A
- EPS Growth
- GLMD N/A
- SNTG N/A
- EPS
- GLMD N/A
- SNTG N/A
- Revenue
- GLMD N/A
- SNTG $146,472.00
- Revenue This Year
- GLMD N/A
- SNTG N/A
- Revenue Next Year
- GLMD N/A
- SNTG N/A
- P/E Ratio
- GLMD N/A
- SNTG N/A
- Revenue Growth
- GLMD N/A
- SNTG N/A
- 52 Week Low
- GLMD $1.21
- SNTG $1.43
- 52 Week High
- GLMD $23.80
- SNTG $3.97
- Technical
- Relative Strength Index (RSI)
- GLMD 31.65
- SNTG 27.83
- Support Level
- GLMD $1.33
- SNTG $1.77
- Resistance Level
- GLMD $1.55
- SNTG $1.85
- Average True Range (ATR)
- GLMD 0.22
- SNTG 0.07
- MACD
- GLMD -0.04
- SNTG -0.04
- Stochastic Oscillator
- GLMD 7.61
- SNTG 5.17
Stock Price Comparison Chart: GLMD vs SNTG
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.